Delivery Order SPE2DB20D6037-SPE2DB23FD0NN
Award Date 7/14/23
Potential Completion Date 7/17/23
Potential Value $5K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,781.12 order is for the supply of 4564906842 - ONDANSETRON ODT 4 MG TABLET 30S to support the recurring medical supply needs of military health facilities. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under...
- This is a firm fixed-price delivery order (SPE2DB20D6037|SPE2DB25FTUK7) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $5,145.07 award is for the delivery of 4566952889 - ONDANSETRON ODT 4 MG TABLET 30S, a pharmaceutical product. The delivery order was issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to procure a wide range...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,736.55, is for the delivery of Ondansetron ODT 4 mg tablets in 30-count packages. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC enables the DLA to issue firm fixed-price...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,083.86 firm fixed-price contract is for the delivery of 4565006417 Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of June 27, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the issuance of...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,568.92, is for the delivery of 4565146337 - ONDANSETRON HCL 4 MG TABLET UD 100S. The contract is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc. under the DLA's SPE2DB program, which has a ceiling value of up to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program to DMS Pharmaceutical Group Inc., a woman-owned small business. The $2,003.65 contract is for the delivery of 4,564,668,857 units of ondansetron HCL 4 mg tablets. The contract has an ultimate completion date of May 21, 2024 and was awarded on May 20, 2024. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Ondansetron ODT 4 mg tablets and has a firm fixed price of $2,778.48 with a completion date of July 9, 2024. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract, valued at $1,104.48, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. This order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that runs through December 31, 2025. The IDC allows DLA to issue delivery orders for a comprehensive range of pharmaceutical items, including both common and...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $1,968.95 and a period of performance through June 11, 2024. The contract is for the delivery of Ondansetron ODT 8 mg tablets to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group has a significant...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,045.09 contract is for the delivery of 4,566,450,193 units of Ondansetron HCL 4 mg tablets by November 18, 2024. The award is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...